Literature DB >> 8431529

A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status.

K Y Yoo1, K Tajima, S Miura, M Yoshida, H Murai, T Kuroishi, Y Lee, H Risch, R Dubrow.   

Abstract

It has been proposed that breast cancers may differ in their pathogenesis and etiology according to their estrogen receptor (ER) and progesterone receptor (PR) status. This hospital-based case-control study in Japan assessed the relationship between known and suspected breast-cancer risk factors and ER and PR status. Information on risk factors was collected from histologically confirmed breast-cancer cases (n = 519) and from cancer-free controls (n = 9,506). Of 160 cases with known ER status, 58 percent were ER-positive; 38 percent of 157 cases with known PR status were PR-positive. No statistically significant differences were found between ER-positive cf ER-negative cases. However, statistically significant differences between PR-positive cf PR-negative cases were observed for number of full-term pregnancies (P = 0.01), menstrual regularity as a teenager (P = 0.024), and occupation as housewife (P = 0.036). Borderline differences were observed for age at menopause (P = 0.074), and age at menarche (P = 0.083). This study provides some evidence that etiologic distinctions may be greater between PR-positive and PR-negative breast cancers than between ER-positive and ER-negative breast cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431529     DOI: 10.1007/bf00051712

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  18 in total

1.  Independent protective effect of lactation against breast cancer: a case-control study in Japan.

Authors:  K Y Yoo; K Tajima; T Kuroishi; K Hirose; M Yoshida; S Miura; H Murai
Journal:  Am J Epidemiol       Date:  1992-04-01       Impact factor: 4.897

2.  Steroid receptor status and the epidemiology of breast cancer.

Authors:  N Kreiger; W D King; L Rosenberg; E A Clarke; J R Palmer; S Shapiro
Journal:  Ann Epidemiol       Date:  1991-11       Impact factor: 3.797

3.  Specific estrogen binding by the cytoplasm fof human breast carcinoma.

Authors:  S G Korenman; B A Dukes
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

4.  Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.

Authors:  A M Ruder; F Lubin; Y Wax; A Geier; E Alfundary; A Chetrit
Journal:  Cancer       Date:  1989-07-01       Impact factor: 6.860

Review 5.  Estrogen receptors and breast cancer.

Authors:  J L Stanford; M Szklo; L A Brinton
Journal:  Epidemiol Rev       Date:  1986       Impact factor: 6.222

6.  Steroid-hormone receptors in breast cancer.

Authors:  J L Wittliff
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

7.  Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.

Authors:  A McTiernan; D B Thomas; L K Johnson; D Roseman
Journal:  J Natl Cancer Inst       Date:  1986-10       Impact factor: 13.506

8.  Estrogen receptors in breast cancer. Association with epidemiologic risk factors.

Authors:  R Ballard-Barbash; M R Griffin; L D Fisher; M A Covalciuc; N S Jiang
Journal:  Am J Epidemiol       Date:  1986-07       Impact factor: 4.897

9.  Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology.

Authors:  M L Lesser; P P Rosen; R T Senie; K Duthie; C Menendez-Botet; M K Schwartz
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

10.  Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study.

Authors:  J A Cooper; T E Rohan; E L Cant; D J Horsfall; W D Tilley
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

View more
  3 in total

1.  Fruit and vegetable intake and risk of breast cancer by hormone receptor status.

Authors:  Seungyoun Jung; Donna Spiegelman; Laura Baglietto; Leslie Bernstein; Deborah A Boggs; Piet A van den Brandt; Julie E Buring; James R Cerhan; Mia M Gaudet; Graham G Giles; Gary Goodman; Niclas Hakansson; Susan E Hankinson; Kathy Helzlsouer; Pamela L Horn-Ross; Manami Inoue; Vittorio Krogh; Marie Lof; Marjorie L McCullough; Anthony B Miller; Marian L Neuhouser; Julie R Palmer; Yikyung Park; Kim Robien; Thomas E Rohan; Stephanie Scarmo; Catherine Schairer; Leo J Schouten; James M Shikany; Sabina Sieri; Schoichiro Tsugane; Kala Visvanathan; Elisabete Weiderpass; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Xuehong Zhang; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  J Natl Cancer Inst       Date:  2013-01-24       Impact factor: 13.506

2.  Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study.

Authors:  A P Høyer; T Jørgensen; F Rank; P Grandjean
Journal:  BMC Cancer       Date:  2001-07-30       Impact factor: 4.430

3.  Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case-control studies in Japan.

Authors:  C Nagata; Y H Hu; H Shimizu
Journal:  Jpn J Cancer Res       Date:  1995-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.